Search Medical Condition
Please enter condition
Please choose location from dropdown
 

One Or Multiple Investigational Sites, Japan Clinical Trials

A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (58018) clinical trials

The purpose of this study is to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in prolonging progression free survival (PFS) in patients with relapsed iNHL who have received one or more lines of treatment, including rituximab and who either had a treatment-free ...

Phase

To determine the safety, tolerability, pharmacokinetics, maximum tolerated dose, or pharmacological active dose of BAY2402234 in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

Phase

Symptoms may include: Feeling sad, blue, hopeless, or worthless Crying spells Trouble sleeping or sleeping too much Difficulty concentrating Unexplained low energy or fatigue Loss of interest or pleasure Changes in weight or appetite Wondering if life is worth living Dr. John Zajecka and other investigators at Rush University Medical ...

Phase N/A

Fever? Aches? Pains? Cough? Sore Throat? When you reach for the tissues this flu season, think Global Medical Research. Global Medical Research is enrolling in a study that will try to find out if an investigational flu drug can speed up the recovery of people with flu.

Phase N/A

Do You Have Pain Due to Endometriosis? Adams Patterson is looking for women to participate in a research study to evaluate whether an investigational medicine could reduce pain due to endometriosis.

Phase N/A

Do you experience heavy bleeding associated with uterine fibroids? Adams Patterson is enrolling volunteers with heavy menstrual bleeding due to uterine fibroids in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

Phase N/A

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

Phase N/A

This is a study for elderly patients (>= 55 years of age) who meet the NINCDS-ADRDA criteria for Alzheimer's Disease. Patients screened at visit 1 who will meet all of the inclusion criteria, will be enrolled in the study and receive study therapy. Qualified volunteers will receive compensation up to ...

Phase N/A